Trial intelligence / Profile preview

Albaconazole Dose-Finding Study in Acute Candida Vulvovaginitis

NCT00199264Phase 2Terminated

Sponsor
Uriach
Start
Jun 2004
Modality
Small Molecules
01

Overview

A Phase 2 trial of albaconazole in vulvovaginal candidiasis (VVC), sponsored by Uriach. Started Jun 2004; status: terminated.

02

Drugs

albaconazole
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on NCT00199264.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00199264.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call